Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Marini

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Annals of the Rheumatic Diseases|July 24, 2007
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximabS Visvanathan, C Wagner, J C Marini, et al.
Human Mutation|May 26, 1998
Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagenA P Sarafova, H Choi, A Forlino, et al.
The Journal of Biological Chemistry|July 25, 1984
Physical characterization of a kinetoplast DNA fragment with unusual propertiesJ C Marini, P N Effron, T C Goodman, et al.
Molecular Genetics and Metabolism|December 14, 2004
Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 geneL C Walker, A S Teebi, J C Marini, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 8, 2014
Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strengthB P Sinder, L E White, J D Salemi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred miceR J Butterfield, J D Sudweeks, E P Blankenhorn, et al.
Arthritis and Rheumatism|April 3, 2008
A type I collagen defect leads to rapidly progressive osteoarthritis in a mouse modelJ M Blair-Levy, C E Watts, N M Fiorentino, et al.
American Journal of Medical Genetics|August 1, 1992
New autosomal recessive syndrome of sparse hair, osteopenia, and mental retardation in Mennonite sistersS G Kaler, A M Garrity, H J Stern, et al.
The AAPS Journal|October 24, 2014
Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization teamS Lowes, R Hucker, M Jemal, et al.
Bone|June 19, 2013
Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfectaJ A Meganck, D L Begun, J D McElderry, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|July 24, 2007
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximabS Visvanathan, C Wagner, J C Marini, et al.
Human Mutation|May 26, 1998
Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagenA P Sarafova, H Choi, A Forlino, et al.
The Journal of Biological Chemistry|July 25, 1984
Physical characterization of a kinetoplast DNA fragment with unusual propertiesJ C Marini, P N Effron, T C Goodman, et al.
Molecular Genetics and Metabolism|December 14, 2004
Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 geneL C Walker, A S Teebi, J C Marini, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 8, 2014
Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strengthB P Sinder, L E White, J D Salemi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred miceR J Butterfield, J D Sudweeks, E P Blankenhorn, et al.
Arthritis and Rheumatism|April 3, 2008
A type I collagen defect leads to rapidly progressive osteoarthritis in a mouse modelJ M Blair-Levy, C E Watts, N M Fiorentino, et al.
American Journal of Medical Genetics|August 1, 1992
New autosomal recessive syndrome of sparse hair, osteopenia, and mental retardation in Mennonite sistersS G Kaler, A M Garrity, H J Stern, et al.
The AAPS Journal|October 24, 2014
Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization teamS Lowes, R Hucker, M Jemal, et al.
Bone|June 19, 2013
Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfectaJ A Meganck, D L Begun, J D McElderry, et al.
Pageof 8